NNC9204-1177

DRUG2 trials

Sponsors

Novo Nordisk A/S

Conditions

Healthy VolunteersMetabolism and Nutrition DisorderObesityOverweight

Phase 1

A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-1177 in Subjects Being Overweight or With Obesity.

CompletedNCT02941042

Novo Nordisk A/SMetabolism and Nutrition Disorder, Obesity

Start: 2016-10-10End: 2017-09-30Updated: 2018-09-05

Research Study to Investigate How a Study Medicine (NNC9204- 1177) Affects Blood Levels of Other Medicines in Healthy People

CompletedNCT04059367

Novo Nordisk A/SHealthy Volunteers, Obesity, Overweight

Start: 2019-08-15End: 2020-01-02Updated: 2020-01-22